Scompenso cardiaco cronico e morte improvvisa: Il messaggio del CIBIS III

Translated title of the contribution: Chronic heart failure and sudden death: The message of CIBIS-III

M. Cristina Dequarti, Luca Poggio, Emilio Vanoli

Research output: Contribution to journalArticle

1 Citation (Scopus)

Abstract

The heart failure is one of the pathologies with major social and economic impact in the western world. The neurohormonal modulation is the only effective pharmacological approach. The increasing use of implantable devices apparently sets against the possibilities of implementing in the patient's treatment scheme. However, the anti-adrenergic therapy, once used at optimal dose, is highly effective on sudden death and on rates of implantable cardioverter defibrillators discharges. CIBIS-III proposes the beta-blocker use as primary approach, even prior to ACE inhibitors. This might be specifically true in the patient whit evidence of autonomic imbalance resulting in sympathetic hyperactivity. CIBIS-III shows that bisoprolol can be used in chronic heart failure patients also in absence of the concomitant enalapril therapy. Using bisoprolol as primary approach allows to reach optimal doses more effective on arrhythmic risk. CIBIS III results propose new strategies to the current international heart failure guidelines's recommendations.

Original languageItalian
Pages (from-to)638-645
Number of pages8
JournalRecenti Progressi in Medicina
Volume98
Issue number12
Publication statusPublished - Dec 2007

Fingerprint

Sudden Death
Bisoprolol
Heart Failure
Western World
Enalapril
Adrenergic Antagonists
Implantable Defibrillators
Angiotensin-Converting Enzyme Inhibitors
Therapeutics
Economics
Pharmacology
Guidelines
Pathology
Equipment and Supplies
Mortality

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Scompenso cardiaco cronico e morte improvvisa : Il messaggio del CIBIS III. / Dequarti, M. Cristina; Poggio, Luca; Vanoli, Emilio.

In: Recenti Progressi in Medicina, Vol. 98, No. 12, 12.2007, p. 638-645.

Research output: Contribution to journalArticle

Dequarti, M. Cristina ; Poggio, Luca ; Vanoli, Emilio. / Scompenso cardiaco cronico e morte improvvisa : Il messaggio del CIBIS III. In: Recenti Progressi in Medicina. 2007 ; Vol. 98, No. 12. pp. 638-645.
@article{1e0827f6bf5c46a086922dba71903657,
title = "Scompenso cardiaco cronico e morte improvvisa: Il messaggio del CIBIS III",
abstract = "The heart failure is one of the pathologies with major social and economic impact in the western world. The neurohormonal modulation is the only effective pharmacological approach. The increasing use of implantable devices apparently sets against the possibilities of implementing in the patient's treatment scheme. However, the anti-adrenergic therapy, once used at optimal dose, is highly effective on sudden death and on rates of implantable cardioverter defibrillators discharges. CIBIS-III proposes the beta-blocker use as primary approach, even prior to ACE inhibitors. This might be specifically true in the patient whit evidence of autonomic imbalance resulting in sympathetic hyperactivity. CIBIS-III shows that bisoprolol can be used in chronic heart failure patients also in absence of the concomitant enalapril therapy. Using bisoprolol as primary approach allows to reach optimal doses more effective on arrhythmic risk. CIBIS III results propose new strategies to the current international heart failure guidelines's recommendations.",
keywords = "Beta-blockers, Heart failure, Sudden death, Sympathetic activity",
author = "Dequarti, {M. Cristina} and Luca Poggio and Emilio Vanoli",
year = "2007",
month = "12",
language = "Italian",
volume = "98",
pages = "638--645",
journal = "Recenti Progressi in Medicina",
issn = "0034-1193",
publisher = "Il Pensiero Scientifico Editore s.r.l.",
number = "12",

}

TY - JOUR

T1 - Scompenso cardiaco cronico e morte improvvisa

T2 - Il messaggio del CIBIS III

AU - Dequarti, M. Cristina

AU - Poggio, Luca

AU - Vanoli, Emilio

PY - 2007/12

Y1 - 2007/12

N2 - The heart failure is one of the pathologies with major social and economic impact in the western world. The neurohormonal modulation is the only effective pharmacological approach. The increasing use of implantable devices apparently sets against the possibilities of implementing in the patient's treatment scheme. However, the anti-adrenergic therapy, once used at optimal dose, is highly effective on sudden death and on rates of implantable cardioverter defibrillators discharges. CIBIS-III proposes the beta-blocker use as primary approach, even prior to ACE inhibitors. This might be specifically true in the patient whit evidence of autonomic imbalance resulting in sympathetic hyperactivity. CIBIS-III shows that bisoprolol can be used in chronic heart failure patients also in absence of the concomitant enalapril therapy. Using bisoprolol as primary approach allows to reach optimal doses more effective on arrhythmic risk. CIBIS III results propose new strategies to the current international heart failure guidelines's recommendations.

AB - The heart failure is one of the pathologies with major social and economic impact in the western world. The neurohormonal modulation is the only effective pharmacological approach. The increasing use of implantable devices apparently sets against the possibilities of implementing in the patient's treatment scheme. However, the anti-adrenergic therapy, once used at optimal dose, is highly effective on sudden death and on rates of implantable cardioverter defibrillators discharges. CIBIS-III proposes the beta-blocker use as primary approach, even prior to ACE inhibitors. This might be specifically true in the patient whit evidence of autonomic imbalance resulting in sympathetic hyperactivity. CIBIS-III shows that bisoprolol can be used in chronic heart failure patients also in absence of the concomitant enalapril therapy. Using bisoprolol as primary approach allows to reach optimal doses more effective on arrhythmic risk. CIBIS III results propose new strategies to the current international heart failure guidelines's recommendations.

KW - Beta-blockers

KW - Heart failure

KW - Sudden death

KW - Sympathetic activity

UR - http://www.scopus.com/inward/record.url?scp=38549098275&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=38549098275&partnerID=8YFLogxK

M3 - Articolo

C2 - 18369041

AN - SCOPUS:38549098275

VL - 98

SP - 638

EP - 645

JO - Recenti Progressi in Medicina

JF - Recenti Progressi in Medicina

SN - 0034-1193

IS - 12

ER -